Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NSC-703786 induces single-strand breaks and DNA-protein crosslinks in breast cancer cells

Nov. 26, 2003

PPI-2458 inhibits primary tumor growth in mouse model of melanoma

Nov. 26, 2003

Increased antitumor activity with new formulations of Panzem

Nov. 26, 2003

Plexxikon and Phenomix to develop novel drugs for oncology and inflammation

Nov. 26, 2003

New hypoxic cytotoxin shows promising in vitro and in vivo activity

Nov. 25, 2003

Antitumor activity of MLN-944 due to inhibition of DNA and RNA synthesis

Nov. 25, 2003

New FTase inhibitors in early development at Janssen

Nov. 25, 2003

Enzon enters collaborative development program with NIH for SS1P

Nov. 25, 2003

Metastatic melanoma as a potential new indication for arsenic trioxide

Nov. 25, 2003

Trabectedin alone or in combination in the treatment of advanced solid tumors

Nov. 25, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...